ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Cancer Prevention: Review Group’s Report Urges Integration Of Prevention with all NCI Research

June 27, 1997

Proposed Regulations for Center Grants In Federal Register

October 29, 1976

Holden, Mayo, Hopkins Win Lymphoma SPOREs; Hutchinson Wins Prostate SPORE

October 4, 2002

An Earmark In The Making? NCI Urged to Boost Gastric Cancer Funding

December 17, 2013

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011